CHD:NYSEChurch & Dwight Company, Inc. Analysis
Data as of 2026-03-10 - not real-time
$101.28
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Church & Dwight is trading firmly above its 20‑day, 50‑day and 200‑day simple moving averages, indicating a sustained bullish bias, while the RSI sits in a neutral zone and the MACD histogram has turned negative, suggesting short‑term momentum pressure. Fundamentally, the company delivers solid profitability margins and a healthy free cash flow conversion, supporting a 1.2% dividend yield with a payout ratio under 40%.
The DCF model values the stock well below its current market price, flagging a potential overvaluation, yet analyst sentiment has recently softened from a sell to a neutral stance, and the consensus price target implies modest upside. Investors should weigh the defensive consumer‑staples positioning and stable cash generation against the premium valuation and near‑term technical weakness.
The DCF model values the stock well below its current market price, flagging a potential overvaluation, yet analyst sentiment has recently softened from a sell to a neutral stance, and the consensus price target implies modest upside. Investors should weigh the defensive consumer‑staples positioning and stable cash generation against the premium valuation and near‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key SMAs but MACD turning bearish
- Support level near $98 providing downside cushion
- Neutral RSI indicating no immediate overbought pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent revenue growth and strong operating margins
- Defensive consumer‑defensive sector with low beta
- Sustainable dividend and solid free cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Premium valuation relative to DCF fair value
- Stable earnings and cash generation supporting dividend
- Long‑term defensive positioning in household and personal care
Key Metrics & Analysis
Financial Health
Revenue Growth3.90%
Profit Margin11.88%
P/E Ratio33.5
ROE17.62%
ROA8.20%
Debt/Equity59.52
P/B Ratio6.0
Op. Cash Flow$1.2B
Free Cash Flow$1.1B
Technical Analysis
TrendBullish
RSI53.6
Support$97.81
Resistance$106.04
MA 20$102.29
MA 50$95.36
MA 200$92.14
MACDBearish
VolumeStable
Fear & Greed Index77.7
Valuation
Fair Value$69.22
Target Price$103.58
Upside/Downside2.27%
GradeOvervalued
TypeBlend
Dividend Yield1.20%
Risk Assessment
Beta0.05
Volatility23.84%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.